Publication: Mesoporous silicon nanoparticles loaded with salinomycin for cancer therapy applications
| dc.contributor.author | Konoplyannikov, M. A. | |
| dc.contributor.author | Le-Deygen, I. M. | |
| dc.contributor.author | Yusubalieva, G. M. | |
| dc.contributor.author | Revkova, V. A. | |
| dc.contributor.author | Eremina, A. S. | |
| dc.contributor.author | Kargina, Y. V. | |
| dc.contributor.author | Kharin, A. | |
| dc.contributor.author | Bazylenko, T. Y. | |
| dc.contributor.author | Timoshenko, V. Y. | |
| dc.contributor.author | Еремина, Анна Сергеевна | |
| dc.contributor.author | Базыленко, Татьяна Юрьевна | |
| dc.contributor.author | Тимошенко, Виктор Юрьевич | |
| dc.date.accessioned | 2024-11-29T21:14:15Z | |
| dc.date.available | 2024-11-29T21:14:15Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | © 2021Mesoporous silicon nanoparticles loaded with salinomycin, a promising anticancer drug, were investigated as potential nanocontainers for cancer therapy. The drug loading and release were studied by means of the infrared spectroscopy, which revealed a gradual release of the drug with rate dependent on the mass ratio between the nanoparticles and salinomycin. In vitro studies revealed that the prepared nanoparticles loaded with salinomycin resulted in a notable cytotoxic effect on human glioblastoma cells, MCF-7 breast cancer cells and multidrug resistant MCF-7/MDR1 cells. In vivo experiments showed a strong suppression of the Lewis lung carcinoma tumor growth for 10–30 days after intraperitoneal administration of the nanocontainers. The obtained results indicate that salinomycin-loaded mesoporous silicon nanoparticles are prospective for mild chemotherapy of both primary cancer tumors and metastasis. The revealed efficiency against chemotherapy-resistant cancer stem cells and possibility of the intraperitoneal administration are very promising for further clinical applications of the prepared nanocontainers. | |
| dc.identifier.citation | Mesoporous silicon nanoparticles loaded with salinomycin for cancer therapy applications / Konoplyannikov, M.A. [et al.] // Microporous and Mesoporous Materials. - 2021. - 328. - 10.1016/j.micromeso.2021.111473 | |
| dc.identifier.doi | 10.1016/j.micromeso.2021.111473 | |
| dc.identifier.uri | https://www.doi.org/10.1016/j.micromeso.2021.111473 | |
| dc.identifier.uri | https://www.scopus.com/record/display.uri?eid=2-s2.0-85116876797&origin=resultslist | |
| dc.identifier.uri | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=WOS_CPL&DestLinkType=FullRecord&UT=WOS:000709958600006 | |
| dc.identifier.uri | https://openrepository.mephi.ru/handle/123456789/24783 | |
| dc.relation.ispartof | Microporous and Mesoporous Materials | |
| dc.title | Mesoporous silicon nanoparticles loaded with salinomycin for cancer therapy applications | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| oaire.citation.volume | 328 | |
| relation.isAuthorOfPublication | 2f277143-d497-43d0-94a0-01d14a4be67c | |
| relation.isAuthorOfPublication | 57ce8f8d-6cb5-453f-bcf3-eeb897754b5c | |
| relation.isAuthorOfPublication | 4cf6bcf1-0992-45ed-af93-68678d96a4da | |
| relation.isAuthorOfPublication.latestForDiscovery | 2f277143-d497-43d0-94a0-01d14a4be67c | |
| relation.isOrgUnitOfPublication | c8407a6f-7272-450d-8d99-032352c76b55 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | c8407a6f-7272-450d-8d99-032352c76b55 |